Endologix, Inc. announced that John McDermott term as a Class II director is expiring at the annual meeting. Mr. McDermott will be stepping down from his role as Chief Executive Officer no later than June 30, 2018, but currently remains in that role while company seek a successor.
Endologix, Inc.
Equities
ELGXQ
US29266S3040
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
+8.38% | 124B | |
-6.58% | 11.02B | |
+1.56% | 8.88B | |
+36.32% | 5.45B | |
-21.55% | 4.74B | |
+8.20% | 3.44B | |
-7.69% | 2.84B | |
-8.42% | 2.15B | |
-5.20% | 2.11B |